Study rare tumors and inherited cancer risk in families
Part of Cancer clinical trials.
This study looks at people who have rare or unusual cancers or who may have an inherited (family) risk for cancer. It helps researchers learn what genetic or other factors might be involved by collecting family history and medical records, including pathology slides.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a personal history of rare or unusual tumors, or a suspected inherited cancer risk
- Or you have a close family history of rare or unusual tumors or a suspected inherited cancer risk
- Your diagnoses must be verifiable using medical records (and possibly pathology slide review)
- You or your legal representative must be able to understand and sign the consent form
- If you are a child under 3, you usually won’t come to the study clinic unless the team says it’s clinically needed
- If you clearly fit another specific hereditary cancer study, you may not be eligible for this one
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
This study looks at how genes passed down in families might increase the chance of getting cancer. It collects samples from children with cancer and their family members to better understand cancer risks.
This study looks for genetic changes that may explain why some people get cancer earlier or more often than expected. It may help identify cancer risk patterns in you and your family, and guide what doctors watch for next.
This study looks at whether DNA (from a tumor or related samples) can help identify inherited cancer risk in people who develop cancer at a young age. It may help families learn more about risk factors and guide future screening or prevention.
This study looks at genetic changes linked to breast, ovarian, or digestive cancers. It may help doctors better understand inherited cancer risks.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.